HA
IDXG

Heartland Advisors’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Heartland Advisors’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-29,894
Closed -$478K – 219
2016
Q3 		$478K Sell
29,894
-49
-0.2% -$1.35K 0.03% 176
2016
Q2 		$988K Hold
29,943
– – 0.06% 170
2016
Q1 		$838K Sell
29,943
-327
-1% -$8.75K 0.04% 169
2015
Q4 		$1.51M Sell
30,270
-1,002
-3% -$112K 0.06% 187
2015
Q3 		$5.66M Buy
31,272
+2,510
+9% +$494K 0.21% 136
2015
Q2 		$4.11M Sell
28,762
-25
-0.1% -$3.47K 0.11% 180
2015
Q1 		$3.89M Buy
28,787
+1,636
+6% +$268K 0.1% 183
2014
Q4 		$4.86M Sell
27,151
-2,345
-8% -$417K 0.1% 190
2014
Q3 		$7.08M Buy
29,496
+110
+0.4% +$36.7K 0.14% 165
2014
Q2 		$12.9M Buy
29,386
+132
+0.5% +$60.9K 0.22% 131
2014
Q1 		$13.4M Buy
29,254
+298
+1% +$155K 0.23% 133
2013
Q4 		$13.9M Buy
28,956
+2,935
+11% +$1.43M 0.24% 130
2013
Q3 		$12.5M Buy
26,021
+2,256
+9% +$1.08M 0.23% 134
2013
Q2 		$11.2M Buy
+23,765
New +$10.8M 0.21% 148

Other funds holding IDXG

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Heartland Advisors's IDXG Position: Q4 2016 in Review

Heartland Advisors sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q4 2016, closing a stake of 29,894 shares — an estimated $478K sold.

Heartland Advisors first reported a position in IDXG in Q2 2013 and held it in 14 quarters. The position peaked at $13.9M in Q4 2013. 14 funds tracked by Wall St. Rank hold IDXG as of Q4 2016.

  • Heartland Advisors reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Heartland Advisors sold 29,894 Interpace Biosciences, Inc. Common Stock shares in Q4 2016, an estimated $478K.
  • Heartland Advisors first reported a position in Interpace Biosciences, Inc. Common Stock in Q2 2013 and held it in 14 quarters.
  • Heartland Advisors's Interpace Biosciences, Inc. Common Stock position peaked at $13.9M in Q4 2013.
  • 14 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q4 2016.

Based on Heartland Advisors's 13F filing for Q4 2016, filed 31 Jan 2017.